LUMIFOLLOW Registry Confirms Sustained 3-Year Performance of Luminor in Real-World Femoropopliteal Disease Three-year data shows durable efficacy and continued safety across complex lesion subsets Barcelona, February 2026. iVascular announces the presentation of the 3-year follow-up results from the... 14 mai Medical Autor: Alexia Ionescu